Business Today
Subscribe
PMS TodayUnion BudgetUS NewsIndiaWeatherBT ShortsNRIEducationElection
BT GolfBT India 100BT Mindrush
Search
Advertisement
Business News
markets
stocks
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd

Shree Ganesh Remedies Ltd Share Price

  • Sector: Pharmaceuticals (Small Cap)
  • Volume: 4,459
Dec 30, 2025
  • BSE
Share
  • Whatsapp
  • Twitter
  • Facebook
₹453.20
₹23.20 (5.40%)
430.00Low
Today’s Performance
464.00High
418.00Low
52 Week’s Performance
950.00High

bt_logoStock Performance

  • 1 Day5.40%
  • 1 Week0.23%
  • 1 Month-6.48%
  • 3 Months-14.57%
  • 6 Months-28.27%
  • 1 Year-32.25%
  • 3 Years22.26%
  • 5 Years25.15%

bt_logoStock Summary

  • Face Value (₹)10.00
  • Beta1.09
  • 52-Week Low (₹)418.00
  • 52-Week High (₹)950.00
  • Price-to-Book (X)*3.60
  • Dividend Yield (%)-
  • Price-to-Earnings (P/E) (X)*27.04
  • Earnings Per Share (₹)15.90
  • Market Cap (₹ Cr.)*552.02
* Values as of last close price

bt_logoCOMPETITORS

BT TV

“India Hit Nur Khan Airbase”: Pakistan Leaders Admit Truth Behind Operation Sindoor2:39“India Hit Nur Khan Airbase”: Pakistan Leaders Admit Truth Behind Operation Sindoor
Exclusive Sting Operation Exposes Mining Mafia, Threats And Illegal Mining In Uttarakhand3:53Exclusive Sting Operation Exposes Mining Mafia, Threats And Illegal Mining In Uttarakhand
2026 Investment Strategy| Arpit Beriwal: Focus on Mid-Cap Banks, Auto, and Telecom Sectors1:372026 Investment Strategy | Arpit Beriwal: Focus On Mid-Cap Banks, Auto, And Telecom Sectors
China Rings Taiwan With Live-Fire Drills After $11B US Arms Deal, Tensions Spike Across Indo-Pacific4:23China Rings Taiwan With Live-Fire Drills After $11B US Arms Deal, Tensions Spike Across Indo-Pacific
New Year Rush: Lakhs Flood India’s Major Temples, VIP Darshan Suspended4:53New Year Rush: Lakhs Flood India’s Major Temples, VIP Darshan Suspended
Supreme Court Pauses Centre’s Aravalli Definition After Protests, Orders Fresh Review2:49Supreme Court Pauses Centre’s Aravalli Definition After Protests, Orders Fresh Review
India AI Impact Summit 2026: India Among Top 3 Global AI Ecosystems, 100+ Nations to Join2:18India AI Impact Summit 2026: India Among Top 3 Global AI Ecosystems, 100+ Nations To Join
Bhuvaneshwari A, MD & CEO, SBICAP Securities, Shares Message For Women1:49Bhuvaneshwari A, MD & CEO, SBICAP Securities, Shares Message For Women
Low Visibility Impacts Train Services, Northern Railways Issues Safety Update5:11Low Visibility Impacts Train Services, Northern Railways Issues Safety Update
BT Most Powerful Women — Breaking Barriers | Hosted At NSE1:17BT Most Powerful Women — Breaking Barriers | Hosted At NSE
View more

bt_logoFAQ's

What was Shree Ganesh Remedies Ltd share price previously?
Shree Ganesh Remedies Ltd share price was up by 5.40% from the previous closing price of ₹430.00.
Who are peers of Shree Ganesh Remedies Ltd?
The peers of Shree Ganesh Remedies Ltd are Sun Pharmaceutical Industries Ltd, Divis Laboratories Ltd, Torrent Pharmaceuticals Ltd, Cipla Ltd, Dr Reddys Laboratories Ltd, Lupin Ltd, Zydus Lifesciences Ltd.
Who is/are the promoter/promoters of Shree Ganesh Remedies Ltd?
The promotor/promotors of Shree Ganesh Remedies Ltd are Chandubhai Kothia, Parth Chandulal Kothia, Gunjan Chandulal Kothia, Maulikkumar Sudani, Parul Sahani, Shruti Rajesh Sohane, Aditya Patel.
What has been 52-week high of Shree Ganesh Remedies Ltd stocks?
The highest price of Shree Ganesh Remedies Ltd stock is ₹950.00 in the last 52-week.
What is the share price of Shree Ganesh Remedies Ltd (SGRL) today on BSE?
As on Dec 30, 2025 Shree Ganesh Remedies Ltd (SGRL)’s share price on BSE is Rs 453.2
What is the market cap of Shree Ganesh Remedies Ltd (SGRL)?
The current market capitalisation of Shree Ganesh Remedies Ltd (SGRL) is 552.02 crores
What is Shree Ganesh Remedies Ltd Share symbol?
The symbol of Shree Ganesh Remedies Ltd is .
What is the PE ratio of Shree Ganesh Remedies Ltd (SGRL)?
The current PE ratio of Shree Ganesh Remedies Ltd (SGRL) is 27.04.
What is the PB ratio of Shree Ganesh Remedies Ltd (SGRL)?
The current PB ratio of Shree Ganesh Remedies Ltd (SGRL) is 3.60.
Today’s High & Low share prices of Shree Ganesh Remedies Ltd (SGRL) on BSE?
Today, the share price of Shree Ganesh Remedies Ltd (SGRL) on BSE touched a high of Rs 464 and a low of Rs 430
What price did Shree Ganesh Remedies Ltd (SGRL) shares open on the BSE today?
On BSE, the share price of Shree Ganesh Remedies Ltd (SGRL) opened at Rs 430
What is the 52-week high of Shree Ganesh Remedies Ltd (SGRL)?
The 52-week high price of Shree Ganesh Remedies Ltd (SGRL) is Rs 950.00
What is the 52-week low of Shree Ganesh Remedies Ltd (SGRL)?
The 52-week low price of Shree Ganesh Remedies Ltd (SGRL) is Rs 418.00

bt_logoAbout Shree Ganesh Rem

Shree Ganesh Remedies Ltd, incorporated in the year 1995, has its registered office in Plot No 6011, GIDC, Ankleshwar, Gujarat, 393002, 91-2646-227777, 91-2646-226422. The main industry in which Shree Ganesh Remedies Ltd operates is Pharmaceuticals - Indian - Bulk Drugs & Formln.

Auditor/Auditors for Shree Ganesh Remedies Ltd is/are Chaudhary Shah & Associates LLP. In the main management, Chandubhai Kothia is chairman and Aditya Patel is the company secretary for Shree Ganesh Remedies Ltd.

  • CK
    Chandubhai KothiaChairman / Executive Director / Managing Director
  • PCK
    Parth Chandulal KothiaExecutive Director / Whole Time Director / CFO
  • GCK
    Gunjan Chandulal KothiaE D & Wholetime Director
  • MS
    Maulikkumar SudaniIndependent Non Exe. Director
  • PS
    Parul SahaniIndependent Non Exe. Director
  • SRS
    Shruti Rajesh SohaneIndependent Non Exe. Director
  • AP
    Aditya PatelCompany Sec. & Compli. Officer

bt_logoTop Stories

DATA SOURCES: Corporate data, historical price & volume data published on this website have been sourced from CMOTS Internet Technologies Pvt. Ltd. BSE Quotes and NSE Quotes have been sourced from BSE Limited and NSE Data & Analytics Limited, respectively. All timestamps reflected here are in IST (Indian Standard Time). Stock Analysis section has been sourced from the mentioned partners.

DISCLAIMER: Any and all content on this website, including the tools/ analysis, is provided to you only for convenience and on an “as-is, as-available” basis without representation and warranties of any kind. The content and any output of such tools/ analysis is for informational purposes only and should not be relied upon or construed as investment advice or guarantee for any specific performance/ returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this website, you agree to the Terms of Service and Privacy Policy.